Pure or mixed basal/squamous tumours present decreased outcomes after neoadjuvant chemotherapy in the GETUG-AFU V05 VESPER trial

Category Primary study
JournalANNALS OF ONCOLOGY
Year 2022
This article has no abstract
Epistemonikos ID: c6b5b4ec88320a3a87b212db4e5a6dcd8f958f8d
First added on: Feb 15, 2025